We're inviting biotech marketing and commercialization leaders to join us for an interactive roundtable on building and evolving value messaging as evidence develops, ensuring it resonates with the specific decision-making stakeholder, whether that's a clinician deciding whether to prescribe or a health plan Medical Director weighing access and coverage.

Led by biotech marketing gurus, Asha Strazzer-Wild and Kelly Wilder, this peer-driven conversation allows participants to trade real-world experience. 

Topics will include:

• Sequencing value messaging from development through commercialization
• Identifying the evidence that matters most to different stakeholders
• Tailoring messaging to specific personas and the decisions they make
• Communicating a consistent value narrative as evidence and audiences evolve

Come ready to talk about what's working, what gets missed, and how to make evidence-based messaging more relevant to the people making prescribing and access decisions.